Fluimucil 300 mg/3 ml Nebulizer Solution 20 Vials

In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219

Fluimucil 300 mg/3 ml solution for nebulizer it's a mucolytic drug based on N-acetylcysteine, produced by Zambon, indicated to facilitate the elimination of thick and viscous mucus from the respiratory tract. It is used in the treatment of acute and chronic bronchitis, pulmonary emphysema, cystic fibrosis and bronchiectasis.

The wording in nebulizer solution allows direct administration by inhalation through the aerosol, ensuring localized and rapid action on the respiratory tract. The package contains 20 single-dose vials of 3 ml, practices for continuous home therapy.

INDICATIONS

Why is Fluimucil 300 mg/3 ml Nebulizer Solution 20 Vials used? What is it for?

Fluimucil contains the active ingredient N-acetylcysteine, which belongs to a group of medicines called mucolytics, used to facilitate the elimination of mucus from the respiratory tract.

Fluimucil is indicated for the treatment of respiratory system diseases characterized by an increase in the production of thick and viscous mucus (thick and viscous hypersecretion) such as:

• inflammation of the bronchi (acute bronchitis, chronic bronchitis and its exacerbations);
• pathology of the pulmonary alveoli (pulmonary emphysema);
• cystic fibrosis (mucoviscidosis);
• dilation of the bronchi (bronchiectasis).

Talk to your doctor if you do not feel better or if you feel worse after 10 days.

CONTRAINDICATIONS AND SIDE EFFECTS

When should Fluimucil 300 mg/3 ml Nebulizer Solution 20 Vials not be used and what side effects can it cause?

Do not take Fluimucil:

• if you are allergic to N-acetylcysteine, or any of the other ingredients of this medicine (listed in section 6);
• if the patient is a child under 2 years of age.

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Frequency not known (frequency of which cannot be established from the available data):

• allergic reactions (hypersensitivity);
• contraction of bronchial muscles (bronchospasm);
• runny nose (rhinorrhea);
• breathing difficulties (bronchial obstruction);
• inflammation of the mouth (stomatitis);
• vomit;
• nausea;
• urticaria;
• rash;
• itching.

In very rare cases, serious skin reactions have occurred (Stevens Johnson syndrome or Lyell syndrome). If you have changes in the mucous membranes or skin, stop taking the medicine and contact your doctor. Furthermore, a reduction in platelet aggregation (prolongation of bleeding time) is possible.

If you get any side effects, talk to your doctor or pharmacist, including any not listed in this leaflet. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

WARNINGS

What are the warnings of Fluimucil 300 mg/3 ml Nebulizer Solution 20 Vials?

Talk to your doctor or pharmacist before taking Fluimucil. Take this medicine with caution and always under your doctor's supervision in the following cases:

• if you suffer from an inflammatory disease of the bronchi called bronchial asthma. Stop taking Fluimucil immediately if you have contraction of the bronchial muscles (bronchospasm);
• if you have suffered from atopy and asthma in the past as you may develop allergic reactions;
• if you are intolerant to histamine as you may develop allergic reactions;
• if you suffer or have suffered from a stomach or intestinal problem called peptic ulcer, especially if you are taking other medicines that cause stomach problems (gastroinjurious medicines) together with Fluimucil.

This medicine may increase the volume of bronchial mucus (bronchial secretions), especially at the beginning of treatment. Therefore, if this occurs and you are unable to eliminate the bronchial secretions by coughing (expectorate), contact your doctor who will show you a method to eliminate the mucus (postural drainage or bronchoaspiration).

Allergic (hypersensitivity/anaphylactoid) reactions may occur with N-acetylcysteine. Checking for signs of an allergic reaction may be necessary.

If you notice a sulfur smell when you open the vial, or the solution turns pink in the opened vial or when you transfer the solution into the aerosol machine, do not worry because this does not indicate any alteration of the medicine.

Laboratory tests: N-acetylcysteine can interfere with some blood and urine tests (colorimetric assay for the determination of salicylates and tests for determining ketones). Tell your doctor that you are taking this medicine before having these tests.

Children: Fluimucil should not be administered to children under 2 years of age, as it can block the bronchi and prevent normal breathing. The same warnings and precautions reported for adults apply to children and adolescents.

FORMAT

What is the format of Fluimucil 300 mg/3 ml Nebulizer Solution 20 Vials?

20 vials of 3 ml

DRUG LEGAL TEXT

Content responsibility

This sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note

The product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.

Data source: Farmadati Italia

Website: www.farmadati.it

The Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.

The Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.